Stemnovate Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Stemnovate General Information

Description

Developer of a medicinal platform designed to accelerate drug discovery. The company's platform uses state-of-the-art technologies, underpinned by experience in tissue procurement, cell biology, high-throughput imaging, and microfluidics, enabling researchers to access customer-friendly and flexible tools for human drug discovery that overcome many of the limitations associated with mammalian cell lines and cell phone models.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • IdeaSpace West
  • Entrepreneurship Centre, 3 Charles Babbage Road
  • Cambridge CB3 0GT
  • England, United Kingdom
+44 01223
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • IdeaSpace West
  • Entrepreneurship Centre, 3 Charles Babbage Road
  • Cambridge CB3 0GT
  • England, United Kingdom
+44 01223

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stemnovate Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private 01-Jan-2026 Completed Generating Revenue
6. Grant 04-Aug-2022 Completed Generating Revenue
5. Angel (individual) 30-Jul-2021 Completed Generating Revenue
4. Early Stage VC (Series A) 02-Nov-2020 Cancelled Generating Revenue
3. Early Stage VC 29-May-2018 Completed Generating Revenue
2. Seed Round 23-Nov-2017 $198K $198K Completed Generating Revenue
1. Grant 01-Oct-2017 $1.11M Completed Generating Revenue
To view Stemnovate’s complete valuation and funding history, request access »

Stemnovate Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Stemnovate’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Stemnovate Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medicinal platform designed to accelerate drug discovery. The company's platform uses state-of-the-art te
Discovery Tools (Healthcare)
Cambridge, United Kingdom
8 As of 2026

Beverly, MA
 

New Orleans, LA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Stemnovate Competitors (31)

One of Stemnovate’s 31 competitors is Thrive Bioscience, a Venture Capital-Backed company based in Beverly, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Thrive Bioscience Venture Capital-Backed Beverly, MA
28bio Venture Capital-Backed New Orleans, LA
Hesperos Venture Capital-Backed Orlando, FL
Emendo Biotherapeutics Formerly VC-backed Jersey City, NJ
Cherry Biotech Venture Capital-Backed Paris, France
You’re viewing 5 of 31 competitors. Get the full list »

Stemnovate Patents

Stemnovate Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4189115-A1 Method of detection Inactive 29-Jul-2020
GB-202011732-D0 Method of detection Inactive 29-Jul-2020
US-20230235415-A1 Method of detection Inactive 29-Jul-2020
WO-2022024019-A1 Method of detection Inactive 29-Jul-2020
EP-4038198-A1 Method Active 03-Oct-2019 C12Q1/6855
To view Stemnovate’s complete patent history, request access »

Stemnovate Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stemnovate Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Angel (individual) Minority
O2h Ventures Venture Capital Minority
To view Stemnovate’s complete investors history, request access »

Stemnovate FAQs

  • When was Stemnovate founded?

    Stemnovate was founded in 2016.

  • Where is Stemnovate headquartered?

    Stemnovate is headquartered in Cambridge, United Kingdom.

  • What is the size of Stemnovate?

    Stemnovate has 8 total employees.

  • What industry is Stemnovate in?

    Stemnovate’s primary industry is Discovery Tools (Healthcare).

  • Is Stemnovate a private or public company?

    Stemnovate is a Private company.

  • What is Stemnovate’s current revenue?

    The current revenue for Stemnovate is .

  • How much funding has Stemnovate raised over time?

    Stemnovate has raised $1.65M.

  • Who are Stemnovate’s investors?

    , , and O2h Ventures have invested in Stemnovate.

  • Who are Stemnovate’s competitors?

    Thrive Bioscience, 28bio, Hesperos, Emendo Biotherapeutics, and Cherry Biotech are some of the 31 competitors of Stemnovate.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process